Peripheral cocaine-blocking agents: New medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles

Drug and Alcohol Dependence

Volumn 48, Issue 3, 1997, Pages 149-151

  Sparenborg, Steven ^a   Vocci, Frank ^a   Zukin, Stephen ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Butyrylcholinesterase; Catalytic antibodies; Enzyme; Medical treatment; Vaccine

Indexed keywords

CATALYTIC ANTIBODY; CHOLINESTERASE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; VACCINE;

BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG PENETRATION; HUMAN; MEDICAL ETHICS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

CANIDAE;

EID: 0030781787     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00072-0     Document Type: Article

References (3)

1. Cohen P.J. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications. Drug Alcohol Depend. 48:1997;167-174.
2. Fox B.S. Development of a therapeutic vaccine for the treatment of cocaine addiction. Drug Alcohol Depend. 48:1997;153-158.
3. Gorelick D.A. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol Depend. 48:1997;159-165.